Skip to content
Home/Companies/Healthcare/Bormioli Pharma
BP

Bormioli Pharma

Healthcare·Italy·Exited 2024·Held 7yr

Bormioli Pharma is a industrials company, headquartered in Sweden.

Entry
2017
Hold
7yr
Exit
2024
Est. EV
–

Who owns Bormioli Pharma?

Bormioli Pharma was owned by Triton Partners through Triton Fund IV (2013 vintage) from 2017 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Triton Partners
Investor
Triton Partners
Triton Fund IV · 2013 · Buyout

Key facts

HQSweden
SectorIndustrials
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from Triton Fund IV

Other portfolio companies in the same fund.

Cobex
Exited 2019
IndustrialsGermany· 2017
to
Eleda Group
Exited 2020
Business ServicesSweden· 2017
to
Glamox
Active
IndustrialsNorway· 2017
Ramudden Global
Exited 2026
Business ServicesSweden· 2017
to
DeepOcean
Active
EnergyNorway· 2016
FlaktGroup
Exited 2025
IndustrialsGermany· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings